BMC Cancer

Article	Citations
Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China	216
Translation and validation of a simplified Chinese version of the psychosocial assessment tool	129
Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system	109
LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study	98
Clinical characteristics, pregnancy outcomes and ovarian function of pregnancy-associated breast cancer patients: a retrospective age-matched study	96
Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study	95
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling	93
Factors associated with recurrence in patients with oral cancer in Mongolia	89
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phas	89
Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial	87
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016	87
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations	82
The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas	76
Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer	74
Simplification of dosimetry in 90Y-radioembolization therapy by dual planar images	72
Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis	68
Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning	67
Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial	63
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma	63
Association between colorectal cancer and arthritis among Americans in 2005–2016	63
Integrating BRCA testing into routine prostate cancer care: a multidisciplinary approach by SIUrO and other Italian Scientific Societies	60
Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations	59
Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma	54
Correction: EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis	53
Surgery lengthens survival for collecting duct carcinoma: analysis of hospital-based cancer registry data in Japan	53

Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation	53
Fully automated segmentation and classification of renal tumors on CT scans via machine learning	51
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma	49
Thoracoscopic three-port single versus multiple intercostal for radical resection of esophageal cancer: a retrospective analysis	49
The significant impact of opium use on various types of cancer: an updated - systematic review and meta-analysis	48
Dynamic changes in immune repertoire profiles in patients with stage III unresectable non-small cell lung cancer during consolidation treatment with immunotherapy	47
Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer	47
Single- versus multi-fraction spine stereotactic radiosurgery (ALL-STAR) for patients with spinal metastases: a randomized phase III trial protocol	47
Pseudocapsule thickness is positively associated with prognosis in patients with clear cell renal cell carcinoma	46
The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model	45
Auxiliary meta-learning strategy for cancer recognition: leveraging external data and optimized feature mapping	45
High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis	44
Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib	42
Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery	42
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer	42
Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer	41
Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing 18F-deoxyglucose positron emission tomography imaging	40
A clinically applicable model more suitable for predicting malignancy or benignity of pulmonary ground glass nodules in women patients	40
Cell fusion enhances energy metabolism of mesenchymal tumor hybrid cells to sustain their proliferation and invasion	40
Effectiveness of educational intervention on women’s participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model	39
Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study	39
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients	39
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients	38
Study protocol for putting the ‘Person’ in the PiCTuRE: an exploratory sequential mixed methods-based design, exploring how precision medicine is implemented and experienced by people living with a pr	38
Establishment of a novel mouse model of colorectal cancer by orthotopic transplantation	38
Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer	38
Factors influencing clinical decision-making and health-related quality of life changes in colorectal cancer patients receiving targeted therapy: a multicenter study in China	38
Safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer (SEGNO): study protocol for an open-label prospective phase II umbrella cli	38
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade	37
Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: a multicenter, propensity score matching analysis	37
Prognostic significance of miR-378 in cancers: a meta-analysis	37
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma	37
RhoB regulates prostate cancer cell proliferation and docetaxel sensitivity via the PI3K-AKT signaling pathway	37
Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer	37
Prediction of STAS in lung adenocarcinoma with nodules ≤ 2 cm using machine learning: a multicenter retrospective study	37
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review	36
Short-term outcomes and quality of life of esophagogastrostomy versus the double-tract reconstruction after laparoscopic proximal gastrectomy	36
Genomic investigation of innate sensing pathways in the tumor microenvironment	36
Exploration of the role of Cuproptosis genes and their related long non-coding RNA in clear cell renal cell carcinoma: a comprehensive bioinformatics study	36
The expression and prognostic value of the epidermal growth factor receptor family in glioma	35
An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer	34
Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma	34
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness	34
Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy	34
Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center	34
High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade	33
Breast cancer quality of care in Syria: screening, diagnosis, and staging	33
Automated Breast Ultrasound (ABUS)-based radiomics nomogram: an individualized tool for predicting axillary lymph node tumor burden in patients with early breast cancer	33
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer	33
Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?	33

Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function	33
An integrated model for prognosis in vulvar squamous cell carcinoma	33
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung	32
Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma	32
Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma	32
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial	32
Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, ca	32
Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets	32
Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018)	32
Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis	31
Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)	31
A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China	31
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis	30
Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion	30
Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms	30
Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma	30
Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer	30
Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer	30
CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma	30
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up	30
Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival	30
Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study	30
Retraction Note: Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac	29
Retraction Note: LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells	29
Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations	29
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma	29
Retraction Note: Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho	29
Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis	29
Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis	29
A CTLA-4 blocking strategy based on Nanobody in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects	29
Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma	29
External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study	29
Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer	29
Rehabilitation after bone marrow transplant compared with usual care to improve patient outcomes (REBOOT): protocol for a randomised controlled trial	29
Eukaryotic initiation factor 4 A-3 promotes glioblastoma growth and invasion through the Notch1-dependent pathway	29
Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event repor	28
Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation	28
A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma	28
Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing	28
HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib	28
Exploring RNA cargo in extracellular vesicles for pleural mesothelioma detection	28
Pattern of Orbito-ocular Tumours in Nigeria: a systematic review	28
Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone	28
First molecules to reactivate RASG12V GTPase activity	28
Holmium laser-assisted laparoscopic partial cystectomy for bladder cancer: a single-institutional pilot study with technical feasibility and short-term oncological outcome	28
Alternating electric fields can improve chemotherapy treatment efficacy in blood cancer cell U937 (non-adherent cells)	28
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherap	28
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation	27
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy	27
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer	27
IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma	27
Molecular and clinical characterization of PTRF in glioma via 1,022 samples	27
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis	27
The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis	27
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population	27
Breast cancer preventive practices and associated factors among reproductive age women in Wadila District, North East Ethiopia: community based cross-sectional study	27
Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study	27
Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators	26
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer	26
LINC00511 enhances LUAD malignancy by upregulating GCNT3 via miR-195-5p	26
Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization	26
The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis	26
A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study	26
MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib	26
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study	26
Association of clinicopathologic and sonographic features with stromal tumor-infiltrating lymphocytes in triple-negative breast cancer	26
Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells	26
Lymphocyte migration regulation related proteins in urine exosomes may serve as a potential biomarker for lung cancer diagnosis	26
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer	26
Effect of bile duct resection on the prognosis of patients with hepatocellular carcinoma combined with extrahepatic bile duct tumor thrombus	26
The genomic and transcriptome characteristics of lung adenocarcinoma patients with previous breast cancer	25
Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer	25
High resolution dermal ultrasound (US) combined with superficial radiation therapy (SRT) versus non-image guided SRT or external beam radiotherapy (XRT) in early-stage epithelial cancer: a comparison	25
Dissection of paracrine/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis	25
CT Scans and Cancer Risks: A Systematic Review and Dose-response Meta-analysis	25
LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis	25
High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma	25
Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers	25
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer	25
Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study	25

Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry	25
Feasibility and potential effectiveness of nurse-led video-coaching interventions for childhood, adolescent, and young adult cancer survivors: the REVIVER study	25
Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC	25
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer	25
Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study	24
The global burden of cancers attributable to occupational factors, 1990–2021	24
Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity	24
Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy	24
Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1	24
Claudin 18.2 expression profile in primary tumors and their ovarian metastases: implications for targeted therapy	24
Up-regulation expression and prognostic significance of Syntaxin4 in kidney renal clear cell carcinoma	24
Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020	24
Glioma angiogenesis is boosted by ELK3 activating the HIF-1$$\alpha$$/VEGF-A signaling axis	24
Geographical variations of cancer incidence in Guadeloupe, French West Indies	24
Effect of exercise-based cancer rehabilitation via telehealth: a systematic review and meta-analysis	24
Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients	24
Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors	24
Prevalence of anxiety, depression, and post-traumatic stress disorder among Omani children and adolescents diagnosed with cancer: a prospective cross-sectional study	24
Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort	23
The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study	23
Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series	23
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data	23
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gas	23
Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells	23
Deep learning for risk stratification of thymoma pathological subtypes based on preoperative CT images	23
Vaginal CO2 laser therapy for genitourinary syndrome in breast cancer survivors—VagLaser study protocol: a randomized blinded, placebo-controlled trial	23
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials	23
Retraction Note: Numb inhibits epithelial-mesenchymal transition via RBP-Jκ-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer	23
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer	23
Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults	23
Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark	23
Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients’ survival by downregulating miR-21	23
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis	23
KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data	23
The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study	23
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features	23
Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study	23
Type 2-like polarization and elevated CXCL4 secretion of monocyte derived macrophages upon internalization of plasma-derived exosomes from head and neck cancer patients	23
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis	23
Preoperative prognostic nutritional index predicts postoperative infectious complications and oncological outcomes after hepatectomy in intrahepatic cholangiocarcinoma	23
High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma	23
The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining	23
Formin-like protein 2 promotes cell proliferation by a p27-related mechanism in human breast cancer cells	23
Safety and feasibility of ultra-long construct navigated minimally invasive spine surgery with adjuvant radiotherapy in extensive spinal metastasis : a comparative analysis	23
Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study	23
Correlation between overall survival and quality of life in colon cancer patients with chemotherapy	23
Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population	22
Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients	22
Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma	22
The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis	22
Identification of CD8+ T-cell exhaustion signatures for prognosis in HBV-related hepatocellular carcinoma patients by integrated analysis of single-cell and bulk RNA-sequencing	22
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China	22
Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma	22
Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations	22
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy	22
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial	22
Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study	22
Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis	22
Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study	22
Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events	22
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis	22
MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR	22
Estimating smoking-attributable lung cancer mortality in Chinese adults from 2000 to 2020: a comparison of three methods	22
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy	21
Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana	21
Understanding referral of patients with cancer in rural Ethiopia: a qualitative study	21
Disparities in oesophageal cancer risk by age, sex, and nativity in Kuwait:1980–2019	21
Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis	21
The real-world efficacy and safety of nivolumab plus chemotherapy in patients with HER2-negative advanced gastric cancer	21
Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy	21
Health-related risk behaviors among U.S. childhood cancer survivors: a nationwide estimate	21
RC48-ADC treatment for patients with HER2-expressing locally advanced or metastatic solid tumors: a real-world study	21
The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide	21
Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil	21
Elemental profiles in distant tissues during tumor progression	21
Comprehensive analysis of surgical strategies and prognosis for non-small cell lung cancer with pleural metastasis detected intraoperatively	21
CapeOX as neoadjuvant chemotherapy for locally advanced rectal cancer: might less be more?	21
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer	21
LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation	21
Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells	21
Risk of developing depression among breast cancer patients in Palestine	21
Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma	21
Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence	21
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines	21
Hiccups in patients with cancer: a multi-site, single-institution study of etiology, severity, complications, interventions, and outcomes	21
Interobserver variability of clinical target volume delineation in patients undergoing breast-conserving surgery without surgical clips: a pilot study on preoperative magnetic resonance simulation	21
Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study	21
Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer	20
A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock	20
Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients	20
Development of preoperative and postoperative models to predict recurrence in postoperative glioma patients: a longitudinal cohort study	20
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor	20
Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland	20
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma	20
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin	20